EUVIMEDEUVIMED entdecken
Crossref

HLA‐B*15 Is Associated With SARS‐CoV‐2 Infection in a Brazilian Population

João V Facco iD, Marcelo Addas-Carvalho, Adriana da Silva Santos Duarte, Audrey B Zangirolami, Bruno D Benites, Sara T O Saad iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von João V Facco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas - UNICAMP, Campinas, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 21 Literaturangaben. Gefördert von: This work was supported by Grant from the National Council for Scientific and Technological Development (CNPq, #401977/2020), The São Paulo Research Foundation….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies have suggested an association between polymorphisms in class I genes of the major histocompatibility complex, specifically the human leukocyte antigen (HLA), and susceptibility to SARS‐CoV‐2. To explore this, 135 individuals with positive serological tests for SARS‐CoV‐2 were recruited. All the samples were collected before the advent of vaccines, avoiding immunization effects. Participants were divided into high and low neutralizing antibody titer groups, and polymorphisms in HLA‐A, HLA‐B, and HLA‐DRB1 genes were examined using PCR‐SSO. Allele prevalence in the study population was compared to the National Bone Marrow Volunteer Donors Register (REDOME) in São Paulo and between the high and low titer groups within the study population. Results indicated that the HLA‐B*15 polymorphism was more prevalent in the COVID‐19 positive group compared to the control population (COVID‐19 = 0.1370; Control = 0.0875; p = 0.0067). The HLA‐B*18 polymorphism was less prevalent in the COVID‐19 group (COVID‐19 = 0.0185; Control = 0.0534; p = 0.0064). Additionally, the HLA‐A*30 polymorphism was more prevalent in the high titer group within the (high = 0.10937; low = 0.02816; p = 0.0125). Other polymorphisms showed no significant differences. These findings align with international studies, suggesting these genes plays a role in COVID‐19 pathophysiology, however, further research is required to fully understand their impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansBrazilMaleFemaleAdultMiddle AgedGenetic Predisposition to DiseasePolymorphism, GeneticGene FrequencyAntibodies, NeutralizingAllelesAgedHLA-B15 AntigenYoung AdultAntibodies, Viral

Stichwörter der Autor:innen

COVID‐19HLA polymorphismneutralizing antibody

Substanzen

Antibodies, NeutralizingHLA-B15 AntigenAntibodies, Viral

Autor:innen und Institutionen

  • Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas - UNICAMP, Campinas, Sao Paulo, Brazil.

ORCID-Profile: João V Facco, Sara T O Saad

Förderung

  • This work was supported by Grant from the National Council for Scientific and Technological Development (CNPq, #401977/2020), The São Paulo Research Foundation…

Zitieren

APA

Facco, J. V., Addas-Carvalho, M., Duarte, A. D. S. S., Zangirolami, A. B., Benites, B. D., & Saad, S. T. O. (2024). HLA‐B*15 Is Associated With SARS‐CoV‐2 Infection in a Brazilian Population. Journal of Medical Virology. https://doi.org/10.1002/jmv.70028

Vancouver

Facco JV, Addas-Carvalho M, Duarte ADSS, Zangirolami AB, Benites BD, Saad STO. HLA‐B*15 Is Associated With SARS‐CoV‐2 Infection in a Brazilian Population. Journal of Medical Virology. 2024. doi:10.1002/jmv.70028

BibTeX
@article{Facco2024,
  author = {Facco, João V and Addas-Carvalho, Marcelo and Duarte, Adriana da Silva Santos and Zangirolami, Audrey B and Benites, Bruno D and Saad, Sara T O},
  title = {HLA‐B*15 Is Associated With SARS‐CoV‐2 Infection in a Brazilian Population},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70028}
}
Kostenlos starten →